NIPTNon-Invasive Prenatal Testing (blood screening)
NIPTNorth Idaho Physical Therapy (est. 1968; various locations)
NIPTNew Information Processing Technologies (International Symposium)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Researchers from the University of Helsinki, University of Tartu, and the Competence Centre on Health Technologies (CCHT) have recently published an article in PLOS ONE, demonstrating a novel computational framework for targeted high-coverage sequencing-based NIPT. This computational analysis framework allows for detection of fetal trisomy and the parental origin of the trisomic chromosome using targeted high-coverage sequencing data of a pregnant patient's blood sample.
While mentioning about the opportunities in the market for non-invasive prenatal testing, the study claims that the swelling adaptability of NIPT in developing countries affords ample growth opportunities to the market players as they play a vital role behind market's growth.
(127) Similar to the ONTP's declaration in 1993, the NIPT's 2007 declaration began by referencing UN efforts on behalf of Indigenous Peoples.
Since 2012, we have seen the widespread international implementation of cell-free DNA screening techniques for Down syndrome, commonly known as NIPT. It involves a simple maternal blood draw.
If we achieve a 100% success rate with NIPT (as Iceland has done) and no children with Down's syndrome are born then no company will feel that warm glow that comes from recognising that children with Down's syndrome have their own special appeal.
NIPT, a blood sample analysed in a laboratory, will now be offered as an additional option to these invasive tests and for women who receive a negative result.
MedGenome's diagnostics tests include many breakthroughs for genetic diagnostics including the first proprietary liquid biopsy (OncoTrack) for monitoring cancer treatment, non-invasive prenatal screening test (NIPT) for pregnant women, carrier screening for couples planning for children, and whole exome sequencing for cost-effective identification of rare mutations.
Vistara[R], a non-invasive prenatal test (NIPT) from Natera, Inc, screens for single-gene disorders after 9 weeks' gestation.
The move has been sparked by a planned NHS roll-out of Non-Invasive Prenatal Testing (NIPT) for high-risk women, which would allow Down's to be indicated by a simple blood test.
In the first case, described in 2013, a 37-year-old woman underwent noninvasive prenatal testing (NIPT) at 13 weeks of gestation and received a test report of "aneuploidy detected, trisomy 13 and monosomy 18" (7).
Therefore, the noninvasive prenatal testing (NIPT) has potential to fundamentally change the current framework of prenatal care and diagnosis.
The influence of NiPt thickness prior to silicidation on the DC performance of SOI MOSFETs has been studied [13].